Bf. Thomas et al., STRUCTURE-ACTIVITY ANALYSIS OF ANANDAMIDE ANALOGS - RELATIONSHIP TO ACANNABINOID PHARMACOPHORE, Journal of medicinal chemistry, 39(2), 1996, pp. 471-479
Anandamides are endogenous fatty acid ethanolamides that have been sho
wn to bind to the cannabinoid receptor and possess cannabimimetic acti
vity yet are structurally dissimilar from the classical cannabinoids f
ound in Cannabis sativa. We have employed molecular dynamics studies o
f a variety of anandamides to characterize their conformational mobili
ty and determine whether there are pharmacophoric similarities with De
lta(9)-THC. We have found that a looped conformation of these arachido
nyl compounds is energetically favorable and that a structural correla
tion between this low-energy conformation and the classical cannabinoi
ds can be obtained with the superposition of (1) the oxygen of the car
boxyamide with the pyran oxygen in Delta(9)THC, (2) the hydroxyl group
of the ethanol with the phenolic hydroxyl group of Delta 9-THC, (3) t
he five terminal carbons and the pentyl side chain of Delta 9-THC, and
(4) the polyolefin loop overlaying with the cannabinoid tricyclic rin
g. The shape similarity is extended to show that other fatty acid etha
nolamides that possess varying degrees of unsaturation also vary in th
eir conformational mobility, which affects their ability to overlay wi
th Delta(9)-THC as described above. Within this series of compounds, t
he most potent analog, the tetraene (arachidonyl) analog (i.e., ananda
mide itself''), was determined to have restricted conformational mobil
ity that favored an optimal pharmacophore overlay with Delta(9)-THC. E
ight pharmacologically active anandamide analogs are shown to have sim
ilar conformational mobility and pharmacophore alignments that are con
formationally accessible. Furthermore, when these compounds are aligne
d to Delta(9)THC according to the proposed pharmacophore overlay, thei
r potencies are predicted by a quantitative model of cannabinoid struc
ture-activity relationships based solely on classical and nonclassical
cannabinoids with a reasonable degree of accuracy. The ability to inc
orporate the pharmacological potency of these anandamides into the can
nabinoid pharmacophore model is also shown to support the relevance of
the proposed pharmacophore model.